Isn’t Killing Jobs Yet—CEOs Fuel AI Arms Race in 2026
Layoffs are being used to finance AI deployments as global AI expenditure rockets toward trillions. CEOs insist the ...
Explore the primary drivers of risk in Dividend Aristocrats ETF, including sector shifts and interest-rate impacts, with practical mitigation tips.
26,217 articlesLayoffs are being used to finance AI deployments as global AI expenditure rockets toward trillions. CEOs insist the ...
A new $6,000 senior tax deduction comes with an income-based phase-out that can trim or erase relief for those who wo...
Markets reassess the Warsh era as fresh inflation figures arrive. Inflation data confirms kevin and pushes investors ...
As AI reshapes markets, critics say consumer data funds the surge while a handful of platforms claim the profits. Thi...
Colorado has been labeled one of the costliest places to live in 2026, a change that directly affects retirees on fix...
Apple posted a record iPhone revenue quarter and strong customer satisfaction, yet the market remains divided on how ...
On-chain tokenized real-world assets approach $30 billion, but DeFi liquidity trails far behind, underscoring uneven ...
Even a $900,000 retirement balance, split across an IRA and a taxable account, can yield only about $36,000 in initia...
Markets edge higher as Tuesday’s best Wall Street analyst calls spotlight Adobe, Meta, and other names across tech, e...
Berkshire Hathaway's July 2026 moves reveal a rotating bet toward cash-generating, earnings-ready names. Delta Air Li...
ConocoPhillips announces a strategic pivot from growth to cash harvesting as it completes the Marathon Oil deal and b...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...